Post Pandemic Planning: What Will Change in Early-Phase Drug Development?

Watch as our early development experts discuss the impact of COVID-19 on sponsor/CDMO relationships moving forward, how Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs and more.

Related Sites

Previous
Next

Additional Resources

Previous
Next
Patheon on LinkedIn
Patheon on Twitter
Patheon YouTube Channel
© 2021 Thermo Fisher Scientific Inc. All rights reserved. Cookie UsePrivacyTerms of UseModern Slavery Statement
Patheon on LinkedIn Patheon on Twitter Patheon YouTube Channel
Cookie UsePrivacyTerms of UseModern Slavery Statement
© 2021 Thermo Fisher Scientific Inc. All rights reserved.